Sienna Biopharmaceuticals's total assets for Q were $43.49M, a decrease of -59.59% from the previous quarter. SNNAQ total liabilities were $20.39M for the fiscal quarter, a -74.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.